author-photo

Regina Berger

Innsbruck Medical University

15

Papers

188

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)

2020 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

2019 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Part I of GANNET53: A European multicenter Phase I/II trial of the Hsp90 inhibitor Ganetespib combined with weekly Paclitaxel in women with high-grade, platinum-resistant Epithelial Ovarian Cancer – a study of the GANNET53 Consortium

2019 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Clinical significance of CHAC1 in breast and ovarian cancer

2012
Show All
- Source
- Cite
- Save
Citations (0)
Toll-Like Receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

2010 Cancer Science
Show All
- Source
- Cite
- Save
Citations (56)